SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005750
Filing Date
2020-05-07
Accepted
2020-05-07 16:33:48
Documents
72
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20200331x10q.htm 10-Q 1640951
2 EX-31.1 ymab-20200331ex311b132aa.htm EX-31.1 20559
3 EX-31.2 ymab-20200331ex3126be63e.htm EX-31.2 20455
4 EX-32.1 ymab-20200331ex321e72d57.htm EX-32.1 9822
5 EX-32.2 ymab-20200331ex3226ddabc.htm EX-32.2 9785
  Complete submission text file 0001558370-20-005750.txt   4982104

Data Files

Seq Description Document Type Size
6 EX-101.INS ymab-20200331.xml EX-101.INS 731937
7 EX-101.SCH ymab-20200331.xsd EX-101.SCH 47496
8 EX-101.CAL ymab-20200331_cal.xml EX-101.CAL 32275
9 EX-101.DEF ymab-20200331_def.xml EX-101.DEF 171715
10 EX-101.LAB ymab-20200331_lab.xml EX-101.LAB 383691
11 EX-101.PRE ymab-20200331_pre.xml EX-101.PRE 330843
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 20857022
SIC: 2834 Pharmaceutical Preparations